Empiric piperacillin-tazobactam versus carbapenems in the treatment of bacteraemia due to extended-spectrum beta-lactamase-producing enterobacteriaceae
10.1371/journal.pone.0153696
Saved in:
Main Authors: | Ng T.M., Khong W.X., Harris P.N.A., De P.P., Chow A., Tambyah P.A., Lye D.C. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
Public Library of Science (PLoS)
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/142883 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Pediatric drug utilization evaluation of cefepime and piperacillin/tazobactam
by: Prasopchoknapaporn P.
Published: (2023) -
Microbiological equivalence of bacteriostatic and bactericidal activities of the sera from healthy volunteers receiving generic piperacillin/tazobactam (Pipertaz) and original piperacillin/tazobactam (Tazocin).
by: Visanu Thamlikitkul, et al.
Published: (2018) -
Carbapenem for Surgical Site Infection Prophylaxis in Prevalent Regions of Extended-Spectrum β-Lactamase Enterobacteriaceae
by: Anucha Apisarnthanarak, et al.
Published: (2020) -
Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)
by: Stewart, AG, et al.
Published: (2021) -
Effectiveness and safety of generic formulation of piperacillin/tazobactam (Astaz-PR) for treatment of infected patients at Siriraj hospital
by: Lantharita Charoenpong, et al.
Published: (2018)